141 All-trans Retinoic Acid Inhibits Cell Proliferation through Upregulation of TET2 in Squamous Cell Cancer
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent non-melanoma skin cancer. All-trans retinoic acid (ATRA) has been previously proposed anti-tumor potential via inhibiting cancer cell growth by binding to the intracellular retinoic acid receptors (RAR). The ten-eleven translocation 2 (TET2) proteins oxidize the epigenetic mark 5-methylcytosine to 5-hydroxymethylcytosine (5hmC) and loss-functions of TET2 leading to hypermethylation have been established in various cancers. However, its role in cSCC remains unknown.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: X. Zhang, L. Shi, Z. Chu, S. Geng Tags: Carcinogenesis and Cancer Genetics Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Dermatology | Genetics | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Squamous Cell Carcinoma | Translocation